AIM ImmunoTech, Inc. (AIM)
0.57
+0.02
(+3.64%)
USD |
NYAM |
Apr 02, 10:47
AIM ImmunoTech Shareholders Equity (Quarterly) : -9.783M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -271.11M |
| Curis, Inc. | 5.462M |
| Plus Therapeutics, Inc. | 3.996M |
| Windtree Therapeutics, Inc. | -11.60M |
| Viskase Holdings, Inc. | 42.08M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.782M |
| Total Liabilities (Quarterly) | 15.56M |
| Debt to Equity Ratio | -0.5005 |
| Current Ratio | 0.5294 |
| Net Debt Paydown Yield | -9.00% |